Insulin resistance is associated with reduced mitochondrial oxidative capacity measured by 31P-magnetic resonance spectroscopy in participants without diabetes from the Baltimore longitudinal study of aging

Elisa Fabbri, Chee W. Chia, Richard G. Spencer, Kenneth W. Fishbein, David A. Reiter, Donnie Cameron, Ariel C. Zane, Zenobia A. Moore, Marta Gonzalez-Freire, Marco Zoli, Stephanie A. Studenski, Rita R. Kalyani, Josephine M. Egan, Luigi Ferrucci

Research output: Contribution to journalArticle

Abstract

Whether individuals with insulin resistance (IR) but without criteria for diabetes exhibit reduced mitochondrial oxidative capacity is unclear; addressing this question could guide research for new therapeutics. We investigated 248 participants without diabetes from the Baltimore Longitudinal Study of Aging (BLSA) to determine whether impaired mitochondrial capacity is associated with prediabetes, IR, and duration and severity of hyperglycemia exposure. Mitochondrial capacity was assessed as the postexercise phosphocreatine recovery time constant (tPCr) by 31P-magnetic resonance spectroscopy, with higher tPCr values reflecting reduced capacity. Prediabetes was defined using the American Diabetes Association criteria from fasting and 2-h glucose measurements. IR and sensitivity were calculated using HOMA-IR and Matsuda indices. The duration and severity of hyperglycemia exposure were estimated as the number of years from prediabetes onset and the average oral glucose tolerance test (OGTT) 2-h glucose measurement over previous BLSA visits. Covariates included age, sex, body composition, physical activity, and other confounders. Higher likelihood of prediabetes, higher HOMA-IR, and lower Matsuda index were associated with longer tPCr. Among 205 participants with previous OGTT data, greater severity and longer duration of hyperglycemia were independently associated with longer tPC. In conclusion, in individuals without diabetes a more impaired mitochondrial capacity is associated with greater IR and a higher likelihood of prediabetes

Original languageEnglish (US)
Pages (from-to)170-176
Number of pages7
JournalDiabetes
Volume66
Issue number1
DOIs
StatePublished - Jan 1 2017

Fingerprint

Baltimore
Prediabetic State
Longitudinal Studies
Insulin Resistance
Magnetic Resonance Spectroscopy
Hyperglycemia
Glucose Tolerance Test
Therapeutic Human Experimentation
Glucose
Phosphocreatine
Body Composition
Fasting

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Insulin resistance is associated with reduced mitochondrial oxidative capacity measured by 31P-magnetic resonance spectroscopy in participants without diabetes from the Baltimore longitudinal study of aging. / Fabbri, Elisa; Chia, Chee W.; Spencer, Richard G.; Fishbein, Kenneth W.; Reiter, David A.; Cameron, Donnie; Zane, Ariel C.; Moore, Zenobia A.; Gonzalez-Freire, Marta; Zoli, Marco; Studenski, Stephanie A.; Kalyani, Rita R.; Egan, Josephine M.; Ferrucci, Luigi.

In: Diabetes, Vol. 66, No. 1, 01.01.2017, p. 170-176.

Research output: Contribution to journalArticle

Fabbri, E, Chia, CW, Spencer, RG, Fishbein, KW, Reiter, DA, Cameron, D, Zane, AC, Moore, ZA, Gonzalez-Freire, M, Zoli, M, Studenski, SA, Kalyani, RR, Egan, JM & Ferrucci, L 2017, 'Insulin resistance is associated with reduced mitochondrial oxidative capacity measured by 31P-magnetic resonance spectroscopy in participants without diabetes from the Baltimore longitudinal study of aging', Diabetes, vol. 66, no. 1, pp. 170-176. https://doi.org/10.2337/db16-0754
Fabbri, Elisa ; Chia, Chee W. ; Spencer, Richard G. ; Fishbein, Kenneth W. ; Reiter, David A. ; Cameron, Donnie ; Zane, Ariel C. ; Moore, Zenobia A. ; Gonzalez-Freire, Marta ; Zoli, Marco ; Studenski, Stephanie A. ; Kalyani, Rita R. ; Egan, Josephine M. ; Ferrucci, Luigi. / Insulin resistance is associated with reduced mitochondrial oxidative capacity measured by 31P-magnetic resonance spectroscopy in participants without diabetes from the Baltimore longitudinal study of aging. In: Diabetes. 2017 ; Vol. 66, No. 1. pp. 170-176.
@article{30b7c7d245254f90a8c319b5136bdf16,
title = "Insulin resistance is associated with reduced mitochondrial oxidative capacity measured by 31P-magnetic resonance spectroscopy in participants without diabetes from the Baltimore longitudinal study of aging",
abstract = "Whether individuals with insulin resistance (IR) but without criteria for diabetes exhibit reduced mitochondrial oxidative capacity is unclear; addressing this question could guide research for new therapeutics. We investigated 248 participants without diabetes from the Baltimore Longitudinal Study of Aging (BLSA) to determine whether impaired mitochondrial capacity is associated with prediabetes, IR, and duration and severity of hyperglycemia exposure. Mitochondrial capacity was assessed as the postexercise phosphocreatine recovery time constant (tPCr) by 31P-magnetic resonance spectroscopy, with higher tPCr values reflecting reduced capacity. Prediabetes was defined using the American Diabetes Association criteria from fasting and 2-h glucose measurements. IR and sensitivity were calculated using HOMA-IR and Matsuda indices. The duration and severity of hyperglycemia exposure were estimated as the number of years from prediabetes onset and the average oral glucose tolerance test (OGTT) 2-h glucose measurement over previous BLSA visits. Covariates included age, sex, body composition, physical activity, and other confounders. Higher likelihood of prediabetes, higher HOMA-IR, and lower Matsuda index were associated with longer tPCr. Among 205 participants with previous OGTT data, greater severity and longer duration of hyperglycemia were independently associated with longer tPC. In conclusion, in individuals without diabetes a more impaired mitochondrial capacity is associated with greater IR and a higher likelihood of prediabetes",
author = "Elisa Fabbri and Chia, {Chee W.} and Spencer, {Richard G.} and Fishbein, {Kenneth W.} and Reiter, {David A.} and Donnie Cameron and Zane, {Ariel C.} and Moore, {Zenobia A.} and Marta Gonzalez-Freire and Marco Zoli and Studenski, {Stephanie A.} and Kalyani, {Rita R.} and Egan, {Josephine M.} and Luigi Ferrucci",
year = "2017",
month = "1",
day = "1",
doi = "10.2337/db16-0754",
language = "English (US)",
volume = "66",
pages = "170--176",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "1",

}

TY - JOUR

T1 - Insulin resistance is associated with reduced mitochondrial oxidative capacity measured by 31P-magnetic resonance spectroscopy in participants without diabetes from the Baltimore longitudinal study of aging

AU - Fabbri, Elisa

AU - Chia, Chee W.

AU - Spencer, Richard G.

AU - Fishbein, Kenneth W.

AU - Reiter, David A.

AU - Cameron, Donnie

AU - Zane, Ariel C.

AU - Moore, Zenobia A.

AU - Gonzalez-Freire, Marta

AU - Zoli, Marco

AU - Studenski, Stephanie A.

AU - Kalyani, Rita R.

AU - Egan, Josephine M.

AU - Ferrucci, Luigi

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Whether individuals with insulin resistance (IR) but without criteria for diabetes exhibit reduced mitochondrial oxidative capacity is unclear; addressing this question could guide research for new therapeutics. We investigated 248 participants without diabetes from the Baltimore Longitudinal Study of Aging (BLSA) to determine whether impaired mitochondrial capacity is associated with prediabetes, IR, and duration and severity of hyperglycemia exposure. Mitochondrial capacity was assessed as the postexercise phosphocreatine recovery time constant (tPCr) by 31P-magnetic resonance spectroscopy, with higher tPCr values reflecting reduced capacity. Prediabetes was defined using the American Diabetes Association criteria from fasting and 2-h glucose measurements. IR and sensitivity were calculated using HOMA-IR and Matsuda indices. The duration and severity of hyperglycemia exposure were estimated as the number of years from prediabetes onset and the average oral glucose tolerance test (OGTT) 2-h glucose measurement over previous BLSA visits. Covariates included age, sex, body composition, physical activity, and other confounders. Higher likelihood of prediabetes, higher HOMA-IR, and lower Matsuda index were associated with longer tPCr. Among 205 participants with previous OGTT data, greater severity and longer duration of hyperglycemia were independently associated with longer tPC. In conclusion, in individuals without diabetes a more impaired mitochondrial capacity is associated with greater IR and a higher likelihood of prediabetes

AB - Whether individuals with insulin resistance (IR) but without criteria for diabetes exhibit reduced mitochondrial oxidative capacity is unclear; addressing this question could guide research for new therapeutics. We investigated 248 participants without diabetes from the Baltimore Longitudinal Study of Aging (BLSA) to determine whether impaired mitochondrial capacity is associated with prediabetes, IR, and duration and severity of hyperglycemia exposure. Mitochondrial capacity was assessed as the postexercise phosphocreatine recovery time constant (tPCr) by 31P-magnetic resonance spectroscopy, with higher tPCr values reflecting reduced capacity. Prediabetes was defined using the American Diabetes Association criteria from fasting and 2-h glucose measurements. IR and sensitivity were calculated using HOMA-IR and Matsuda indices. The duration and severity of hyperglycemia exposure were estimated as the number of years from prediabetes onset and the average oral glucose tolerance test (OGTT) 2-h glucose measurement over previous BLSA visits. Covariates included age, sex, body composition, physical activity, and other confounders. Higher likelihood of prediabetes, higher HOMA-IR, and lower Matsuda index were associated with longer tPCr. Among 205 participants with previous OGTT data, greater severity and longer duration of hyperglycemia were independently associated with longer tPC. In conclusion, in individuals without diabetes a more impaired mitochondrial capacity is associated with greater IR and a higher likelihood of prediabetes

UR - http://www.scopus.com/inward/record.url?scp=85007392838&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85007392838&partnerID=8YFLogxK

U2 - 10.2337/db16-0754

DO - 10.2337/db16-0754

M3 - Article

C2 - 27737951

AN - SCOPUS:85007392838

VL - 66

SP - 170

EP - 176

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 1

ER -